Next Article in Journal / Special Issue
Design and Potential of Non-Integrating Lentiviral Vectors
Previous Article in Journal / Special Issue
Decoding the Pluripotency Network: The Emergence of New Transcription Factors
Biomedicines 2014, 2(1), 1-13; doi:10.3390/biomedicines2010001
Review

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins

1,* , 1
, 1
, 1,2
, 3
 and 1
Received: 19 November 2013; in revised form: 17 January 2014 / Accepted: 17 January 2014 / Published: 24 January 2014
(This article belongs to the Special Issue Feature Papers)
View Full-Text   |   Download PDF [319 KB, uploaded 24 January 2014]   |   Browse Figure
Abstract: Conjugates of small molecule drugs with antibodies (ADCs) and with other proteins (protein-drug conjugates, PDC) are used as a new class of targeted therapeutics combining the specificity of monoclonal antibodies (mAbs) and other proteins with potent cytotoxic activity of small molecule drugs for the treatment of cancer and other diseases. A(P)DCs have three major components, antibody (targeting protein), linker and payload, the cytotoxic drug. Recently, advances in identifying targets, selecting highly specific mAbs of preferred isotypes, optimizing linker technology and improving chemical methods for conjugation have led to the approval of two ADCs by Food and Drug Administration (FDA) and more than 30 ADCs in advanced clinical development. However, the complex and heterogeneous nature of A(P)DCs often cause poor solubility, instability, aggregation and eventually unwanted toxicity. This article reviews the main components of A(P)DCs, and discusses the choices for drugs, linkers and conjugation methods currently used. Future work will need to focus on developments and strategies for overcoming such major problems associated with the A(P)DCs.
Keywords: antibody-drug conjugates; ADC; biotherapeutics; drugs; biologics antibody-drug conjugates; ADC; biotherapeutics; drugs; biologics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Feng, Y.; Zhu, Z.; Chen, W.; Prabakaran, P.; Lin, K.; Dimitrov, D.S. Conjugates of Small Molecule Drugs with Antibodies and Other Proteins. Biomedicines 2014, 2, 1-13.

AMA Style

Feng Y, Zhu Z, Chen W, Prabakaran P, Lin K, Dimitrov DS. Conjugates of Small Molecule Drugs with Antibodies and Other Proteins. Biomedicines. 2014; 2(1):1-13.

Chicago/Turabian Style

Feng, Yang; Zhu, Zhongyu; Chen, Weizao; Prabakaran, Ponraj; Lin, Kedan; Dimitrov, Dimiter S. 2014. "Conjugates of Small Molecule Drugs with Antibodies and Other Proteins." Biomedicines 2, no. 1: 1-13.


Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert